AI Analysis
Log in to generate an AI summary for this stock.
Log in to generate a MOAT report for this stock.
Log in to generate an earnings report for this stock.
Log in to generate an operating leverage report for this stock.
Log in to generate a management report for this stock.
Log in to generate a valuation report for this stock.
Marvel Biosciences Corp.
CAD 0.15
+$0.01 (+11.11%)
TSXV · 11 Sep 2026 19:58 UTC
Previous Close
CAD 0.14
Day Range
CAD 0.12CAD 0.15
Year Range
CAD 0.12CAD 0.26
Market Cap
9.45M
AVG Volume
69.82K
Trailing/Forward PE
-5.62/-
PEG ratio
-0.3
Dividend Yield
-
Next Earnings Date
-
Primary Exchange
Toronto Stock Exchange Ventures
Video analysis: MRVL.V
All videosNo video analysis for this stock yet. Request one from our team.
News: MRVL.V
Marvel Biosciences annonce la prolongation de la date limite de clôture du placement privé
Calgary, Alberta--(Newsfile Corp. - 9 septembre 2026) - Marvel Biosciences Corp. (TSXV: MRVL) (OTCQB: MBCOF) (« Marvel » ou la
Marvel Biosciences Announces Grant of Deferred Share Units
Calgary, Alberta--(Newsfile Corp. - September 1, 2026) - Marvel Biosciences Corp. (TSXV: MRVL) and its wholly owned subsidiary, Marvel Biotechnology
Similar companies
-
Pharmala Biotech Holdings Inc.
MDMA.CN
·
Canadian Securities Exchange
Compare
-
PharmaTher Holdings Ltd.
PHRM.CN
·
Canadian Securities Exchange
Compare
-
BetterLife Pharma Inc.
BETR.CN
·
Canadian Securities Exchange
Compare
-
Medicure Inc.
MPH.V
·
Toronto Stock Exchange Ventures
Compare
-
Comprehensive Healthcare Systems, Inc.
CHS.V
·
Toronto Stock Exchange Ventures
Compare
-
Glow Lifetech Corp.
GLOW.CN
·
Canadian Securities Exchange
Compare